Covishield Emergency Use Approved By Expert Drug Panel


India’s expert drug panel approved the vaccine developed by Oxford- AstraZeneca ‘Covishield’ against the deadly virus which has killed above 1.5 lakh and weakened more than 1 crore Indians.

According to Reuters, the Subject Expert Committee of the Drug Controller General of India (DCGI) gave its approval to Covishield, the vaccine developed by the Serum Institute of India, Pune on Friday. The approved vaccine shall be sent to the DCGI for final approval. Bharat BioTech, the other vaccine candidate developing Covaxin, has been asked to furnish more data concerning its efficacy.


The Serum Institute of India (SII) had signed a contract with AstraZeneca for the production of over 1 billion vaccine doses for the low and middle-income countries. Out of which, the SII has already stockpiled over 100 million doses.

According to sources, Covishield would be available within the next week and like that in the United Kingdom, the vaccine must be administered in two doses, the second one given within 4-12 weeks after the first.

Covishield, similar to the ‘Oxford’ vaccine developed by the vaccine group of Oxford University and marketed by AstraZeneca, was approved by Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday.

The company is now allowed to deliver its vaccine to the prioritized groups first, and then to the general public, despite not completing a thorough safety assessment.

In the UK, the vaccine’s performance was assessed in volunteers who were administered doses four weeks apart, and yet there is no concrete evidence of the duration of its protectiveness.Everything About New COVID-19 Variant You Need to Know

The MHRA took this decision after they witnessed a spike in the number of cases, ensuring that people receive at least a single dosage of the vaccine.

Currently, Covishield is being administered to over 1600 volunteers as a part of its phase 2/3 trial. The results of these trials, however, have not yet been published in scientific journals.

Inside sources have mentioned that the phase 3 trials are ongoing whose data is continuously under review. Apart from one single case in Chennai where severe reactions from the vaccine were reported, no such incident has been uncovered. It was ruled out that such a reaction was unrelated to the vaccine.

The initial data on the vaccine’s efficacy from India suggested that it was close to what was noticed in the UK as well as in Brazil that formed the base on which the UK relied for the vaccine’s approval.Vaccine Passport:How Does It Work and Why Is It Necessary?

There has been no communication on the part of the Health Ministry regarding the accorded approval but the conditions under which such approval was accorded may be announced on Saturday.

Drugs Controller General, Dr, V.G. Somani raised expectations regarding the virus at an event on Thursday by hinting at a “New Year gift”.

ALSO READ: 5 Best Ayurvedic Food Items To Keep Your Lungs Healthy

Follow Flickonclick on Google News

Related articles

India’s best places for trekking in Winter. Checkout Now

There are plenty of things to do this winter season but what tops them all other than an...

Single Women Choose to Live Independent and Happy.Period

'Single women' is a term used in the society with a special mention but why is 'single men'...

Pune Currently Hosting Oxford University’s Coronavirus Vaccine Phase 3 Trials

Oxford University has been collaborating with the Serum Institute of India (SII) for the development of coronavirus vaccine....

Ber Or Jujube is A Great Immunity Booster Food, Says Rujuta Diwekar

An unexpected surge in the COVID-19 cases in the world has made everyone worry about their health. People...

Celebrate This Year’s Republic Day with New Offers from Apple India Store

A piece of great news arrived for Apple’s gadget lovers. The Apple store India is going to run...

List of Every Major Exams Being Postponed Due To Lockdown, New Dates Here

The pandemic is back in full swing and every state government along with the central government is taking...

“There is No Humiliation more Abusive Than Hunger”- Pranab Mukherjee

Former President of India and Congress party old-hand Pranab Mukherjee passed away on Monday at the age of 84....

Gandhi Jayanti Special: Facts About Mahatma Gandhi We Bet You Never Knew

Mahatma Gandhi was a loved soul, and to this date, we cannot honor him enough. On the occasion...